Mourey RJ[au] - Search Results

Year	Number of Results
1985	1
1989	1
1990	2
1992	2
1993	2
1994	2
1996	2
2002	1
2007	2
2009	3
2010	3
2011	1
2023	0

1

Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).

Anderson DR, Meyers MJ, Vernier WF, Mahoney MW, Kurumbail RG, Caspers N, Poda GI, Schindler JF, Reitz DB, Mourey RJ. Anderson DR, et al. Among authors: mourey rj. J Med Chem. 2007 May 31;50(11):2647-54. doi: 10.1021/jm0611004. Epub 2007 May 5. J Med Chem. 2007. PMID: 17480064

2

Benzothiophene inhibitors of MK2. Part 1: structure-activity relationships, assessments of selectivity and cellular potency.

Anderson DR, Meyers MJ, Kurumbail RG, Caspers N, Poda GI, Long SA, Pierce BS, Mahoney MW, Mourey RJ. Anderson DR, et al. Among authors: mourey rj. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4878-81. doi: 10.1016/j.bmcl.2009.02.015. Epub 2009 Feb 8. Bioorg Med Chem Lett. 2009. PMID: 19616945

3

Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury.

Pengal R, Guess AJ, Agrawal S, Manley J, Ransom RF, Mourey RJ, Benndorf R, Smoyer WE. Pengal R, et al. Among authors: mourey rj. Am J Physiol Renal Physiol. 2011 Sep;301(3):F509-19. doi: 10.1152/ajprenal.00661.2010. Epub 2011 May 25. Am J Physiol Renal Physiol. 2011. PMID: 21613416 Free PMC article.

4

Purification and kinetic characterization of the mitogen-activated protein kinase phosphatase rVH6.

Wiland AM, Denu JM, Mourey RJ, Dixon JE. Wiland AM, et al. Among authors: mourey rj. J Biol Chem. 1996 Dec 27;271(52):33486-92. doi: 10.1074/jbc.271.52.33486. J Biol Chem. 1996. PMID: 8969212 Free article.

5

Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in rats.

Chiang PC, South SA, Daniels JS, Anderson DR, Wene SP, Albin LA, Mourey RJ, Selbo JG. Chiang PC, et al. Among authors: mourey rj. J Pharm Sci. 2009 Jan;98(1):248-56. doi: 10.1002/jps.21425. J Pharm Sci. 2009. PMID: 18449936

6

Purification and characterization of the inositol 1,4,5- trisphosphate receptor protein from rat vas deferens.

Mourey RJ, Verma A, Supattapone S, Snyder SH. Mourey RJ, et al. Biochem J. 1990 Dec 1;272(2):383-9. doi: 10.1042/bj2720383. Biochem J. 1990. PMID: 2176461 Free PMC article.

7

Biochemical, cellular, and anti-inflammatory properties of a potent, selective, orally bioavailable benzamide inhibitor of Rho kinase activity.

Rajagopalan LE, Davies MS, Kahn LE, Kornmeier CM, Shimada H, Steiner TA, Zweifel BS, Wendling JM, Payne MA, Loeffler RF, Case BL, Norton MB, Parikh MD, Nemirovskiy OV, Mourey RJ, Masferrer JL, Misko TP, Kolodziej SA. Rajagopalan LE, et al. Among authors: mourey rj. J Pharmacol Exp Ther. 2010 Jun;333(3):707-16. doi: 10.1124/jpet.110.166033. Epub 2010 Mar 12. J Pharmacol Exp Ther. 2010. PMID: 20228155

8

Inositol 1,4,5-trisphosphate receptors: immunohistochemical localization to discrete areas of rat central nervous system.

Sharp AH, Dawson TM, Ross CA, Fotuhi M, Mourey RJ, Snyder SH. Sharp AH, et al. Among authors: mourey rj. Neuroscience. 1993 Apr;53(4):927-42. doi: 10.1016/0306-4522(93)90478-x. Neuroscience. 1993. PMID: 8389431

9

[3H]noscapine binding sites in brain: relationship to indoleamines and the phosphoinositide and adenylyl cyclase messenger systems.

Mourey RJ, Dawson TM, Barrow RK, Enna AE, Snyder SH. Mourey RJ, et al. Mol Pharmacol. 1992 Oct;42(4):619-26. Mol Pharmacol. 1992. PMID: 1331753

10

Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation.

Mauro LJ, Olmsted EA, Skrobacz BM, Mourey RJ, Davis AR, Dixon JE. Mauro LJ, et al. Among authors: mourey rj. J Biol Chem. 1994 Dec 2;269(48):30659-67. J Biol Chem. 1994. PMID: 7527035 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results